When combined with dermabrasion, the RECELL Autologous Cell Harvesting Device speeds the healing of facial acne scars, according to a study in Aesthetic Plastic Surgery.
The RECELL System uses a small amount of a patient’s own skin to prepare Spray-On Skin Cells at the point of care. It is currently approved by the U.S. Food and Drug Administration for the treatment of acute thermal burns in patients 18 years and older. In international markets, the System is approved to promote skin healing in a wide range of applications including burns, acute and chronic wounds, scars, and vitiligo.
The retrospective study analyzed the healing time and rate of postoperative complications of 78 patients with acne scars treated using dermabrasion with and without the RECELL System, revealing a statistically significant difference in healing time (P\ 0.001) between the two treatment regimens.
Acne scars treated using dermabrasion healed more quickly on average with RECELL (5.27 ± 1.086 days) than without RECELL (average healing time of 12.30 ± 1.725 days). In addition, there were no postoperative complications, such as pigmentation and scar hyperplasia, and higher patient satisfaction rates (P< 0.001) for those patients treated with RECELL, the study showed.
“It’s exciting to see physicians worldwide interested in studying the possible application of the RECELL System to advance patient care across a broad range of treatments,” says Andrew Quick, AVITA Medical’s Chief Technology Officer, in a news release. “We look forward to continued collaboration within the global medical community as we explore the full potential of this regenerative technology platform to address unmet medical needs.”